Press What’s news at AbelsonTaylor Group
Select category
Moving Into 2024
Applying his background in pharmacology, Jeff Berg, President of AbelsonTaylor Group, discusses a particularly exciting use of AI in drug discovery that is tackling one of biology’s biggest challenges – predicting the 3D shape of proteins and designing them from scratch. Read more at https://www.pharmalive.com/healthcare-agency-roundtable-2024-moving-into-2025/
Media Contact:
Recent Posts
What pharma marketers should know about Bluesky
In the ever-changing world of social media, Bluesky has emerged as an intriguing new platform, particularly for HCPs and the...
In the News Read more What pharma marketers should know about BlueskyAbelsonTaylor Group Launches Pro Bono Initiative to Support Chicagoland Health and Wellness Innovators
AbelsonTaylor Group, one of the nation’s leading independent healthcare advertising agencies, is proud to announce the launch of UNITE, a...
Read Press Read more AbelsonTaylor Group Launches Pro Bono Initiative to Support Chicagoland Health and Wellness InnovatorsThink Tank – Creating the Optimal Omnichannel Media Mix
Senior Media Director Terence Prudhomme talks to PM360 Think Tank about why omnichannel marketing is more about audience data than...
In the News Read more Think Tank – Creating the Optimal Omnichannel Media MixConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.